116 related articles for article (PubMed ID: 17198565)
1. [The clinical significance of expression and amplification of FGF3 in bladder transitional cell carcinoma].
Zhang YH; Xie D; Luo JH; Chen W; Chen LW; Xu QC
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2556-9. PubMed ID: 17198565
[TBL] [Abstract][Full Text] [Related]
2. [The detection of protein expression of clusterin and Ki-67 and the status of cell apoptosis in bladder transitional cell carcinoma].
Chen W; Xie D; Luo JH; Wang CX; Tao Y; Zheng KL; Mei H
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):111-4. PubMed ID: 16620672
[TBL] [Abstract][Full Text] [Related]
3. [The clinico-pathological significance of protein expression of PAK1 in bladder transitional cell carcinoma].
Zhang YH; Xie D; Luo JH; Chen W; Chen LW; Xu QC; Liu GY; Ma HB; Lin WQ
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2710-3. PubMed ID: 18167251
[TBL] [Abstract][Full Text] [Related]
4. HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
Coogan CL; Estrada CR; Kapur S; Bloom KJ
Urology; 2004 Apr; 63(4):786-90. PubMed ID: 15072912
[TBL] [Abstract][Full Text] [Related]
5. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
[TBL] [Abstract][Full Text] [Related]
6. [Smad4 and TGF-beta1 expression and clinical significance in bladder transitional cell carcinoma].
Tang ZY; Yang LY; Zhang YJ; Peng KL; Qi L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):363-6. PubMed ID: 16859125
[TBL] [Abstract][Full Text] [Related]
7. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
[TBL] [Abstract][Full Text] [Related]
8. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
9. [Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance].
Shen HW; Yi L; Wang XM; Yao MJ; Deng JW; Fang JZ; Li MN
Ai Zheng; 2004 Feb; 23(2):181-4. PubMed ID: 14960240
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder.
Wang X; Zhang S; MacLennan GT; Eble JN; Lopez-Beltran A; Yang XJ; Pan CX; Zhou H; Montironi R; Cheng L
Clin Cancer Res; 2007 Feb; 13(3):953-7. PubMed ID: 17289890
[TBL] [Abstract][Full Text] [Related]
11. [The mRNA expression of platelet-derived endothelial cell growth factor of bladder transitional cell carcinoma and its relation to invasiveness].
Li G; Zhang YF; Ding Q; Wen DG; Yan CY
Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):30-2. PubMed ID: 15059350
[TBL] [Abstract][Full Text] [Related]
12. [Expression of cyclooxygenase-2 in bladder transitional cell carcinoma and the significance thereof].
Yu L; Chen XJ; Shi PQ; Ding Q; Sun CH; Liu GB; Shi DM; Huang YG
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2683-4. PubMed ID: 19080686
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of GST-Pi and HIF-1alpha in bladder carcinoma].
Deng JH; Bai JL; Ma PC; Zhang SS; Wan JH
Ai Zheng; 2006 Feb; 25(2):190-3. PubMed ID: 16480584
[TBL] [Abstract][Full Text] [Related]
14. C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results.
Leonardo C; Merola R; Orlandi G; Leonardo F; Rondoni M; De Nunzio C
J Exp Clin Cancer Res; 2005 Dec; 24(4):633-8. PubMed ID: 16471327
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological significance of expression and amplification of P21-activated kinase 1 gene in colorectal carcinoma].
Li ZX; Zeng SD; Liu YD; Liao YJ; Hua WF; Lin F; Xie D
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):185-8. PubMed ID: 19296259
[TBL] [Abstract][Full Text] [Related]
16. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
Oeggerli M; Tomovska S; Schraml P; Calvano-Forte D; Schafroth S; Simon R; Gasser T; Mihatsch MJ; Sauter G
Oncogene; 2004 Jul; 23(33):5616-23. PubMed ID: 15122326
[TBL] [Abstract][Full Text] [Related]
17. Novel approach of human epidermal growth factor receptor 2 detection in noninvasive and invasive transitional cell carcinoma of the bladder.
Hauser-Kronberger C; Peham K; Grall J; Rausch W; Hutarew G; Dietze O
J Urol; 2006 Mar; 175(3 Pt 1):875-80; discussion 880. PubMed ID: 16469569
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques.
Nedjadi T; Al-Maghrabi J; Assidi M; Dallol A; Al-Kattabi H; Chaudhary A; Al-Sayyad A; Al-Ammari A; Abuzenadah A; Buhmeida A; Al-Qahtani M
BMC Cancer; 2016 Aug; 16():653. PubMed ID: 27539085
[TBL] [Abstract][Full Text] [Related]
19. [Expression of MUC1 and distribution of tumor-infiltrating dentritic cells in human bladder transitional cell carcinoma].
Xiang ST; Zhou SW; Guan W; Liu JH; Ye ZQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1114-8. PubMed ID: 16174576
[TBL] [Abstract][Full Text] [Related]
20. Is quantitative real-time RT-PCR an adjunct to immunohistochemistry for the evaluation of ErbB2 status in transitional carcinoma of the bladder?
Amsellem-Ouazana D; Bièche I; Molinié V; Elie C; Vieillefond A; Tozlu S; Botto H; Debré B; Lidereau R
Eur Urol; 2006 Jun; 49(6):1035-42; discussion 1042-3. PubMed ID: 16466848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
